🇺🇸 Zinc gluconate supplement in United States

FDA authorised Zinc gluconate supplement on 5 May 1987

Marketing authorisations

FDA — authorised 5 May 1987

  • Application: NDA019229
  • Marketing authorisation holder: ABRAXIS PHARM
  • Local brand name: ZINC SULFATE
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 18 July 2019

  • Application: NDA209377
  • Marketing authorisation holder: AM REGENT
  • Local brand name: ZINC SULFATE
  • Indication: SOLUTION — INTRAVENOUS
  • Status: approved

Read official source →

FDA — authorised 3 May 2022

  • Application: ANDA216249
  • Marketing authorisation holder: GLAND
  • Local brand name: ZINC SULFATE
  • Indication: SOLUTION — INTRAVENOUS
  • Status: approved

Read official source →

FDA — authorised 27 December 2022

  • Application: ANDA216145
  • Marketing authorisation holder: FRESENIUS KABI USA
  • Local brand name: ZINC SULFATE
  • Indication: SOLUTION — INTRAVENOUS
  • Status: approved

Read official source →

FDA — authorised 22 August 2023

  • Application: ANDA217074
  • Marketing authorisation holder: ZYDUS PHARMS
  • Local brand name: ZINC SULFATE
  • Indication: SOLUTION — INTRAVENOUS
  • Status: approved

Read official source →

FDA — authorised 10 June 2024

  • Application: ANDA218059
  • Marketing authorisation holder: APOTEX
  • Local brand name: ZINC SULFATE
  • Indication: SOLUTION — INTRAVENOUS
  • Status: approved

Read official source →

FDA — authorised 5 July 2024

  • Application: ANDA214597
  • Marketing authorisation holder: NIVAGEN PHARMS INC
  • Local brand name: ZINC SULFATE
  • Indication: SOLUTION — INTRAVENOUS
  • Status: approved

Read official source →

FDA — authorised 17 July 2024

  • Application: ANDA216135
  • Marketing authorisation holder: SOMERSET THERAPS LLC
  • Local brand name: ZINC SULFATE
  • Indication: SOLUTION — INTRAVENOUS
  • Status: approved

Read official source →

FDA — authorised 1 May 2025

  • Application: ANDA219585
  • Marketing authorisation holder: ASPIRO
  • Local brand name: ZINC SULFATE
  • Indication: SOLUTION — INTRAVENOUS
  • Status: approved

Read official source →

FDA — authorised 10 June 2025

  • Application: ANDA217624
  • Marketing authorisation holder: STIRA
  • Local brand name: ZINC SULFATE
  • Indication: SOLUTION — INTRAVENOUS
  • Status: approved

Read official source →

Frequently asked questions

Is Zinc gluconate supplement approved in United States?

Yes. FDA authorised it on 5 May 1987; FDA authorised it on 18 July 2019; FDA authorised it on 3 May 2022.

Who is the marketing authorisation holder for Zinc gluconate supplement in United States?

ABRAXIS PHARM holds the US marketing authorisation.